Alnylam Pharmaceuticals

American biopharmaceutical company

📊 Rating

2 news mentions · 👍 0 likes · 👎 0 dislikes

📌 Topics

Stock Downgrade (1)
Valuation Concerns (1)

🏷️ Keywords

Jefferies (1) · Alnylam (1) · stock rating (1) · downgrade (1) · valuation (1) · biotech (1) · analyst (1) · overvalued (1)

📖 Key Information

Alnylam Pharmaceuticals, Inc. is an American biopharmaceutical company focused on the discovery, development and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases. The company was founded in 2002 and is headquartered in Cambridge, Massachusetts.

📰 Related News (2)

🇺🇸 H.C. Wainwright reiterates Alnylam stock rating at buy, $510 target (2026-03-26)
🇺🇸 Jefferies downgrades Alnylam stock rating on valuation concerns (2026-03-16)

🔗 Entity Intersection Graph

People and organizations frequently mentioned alongside Alnylam Pharmaceuticals:

🌐
Jefferies · 1 shared articles